WikiPathways<p>Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion. <a href="https://doi.org/10.1186/s10020-023-00664-z" rel="nofollow noopener noreferrer" target="_blank"><span class="invisible">https://</span><span class="ellipsis">doi.org/10.1186/s10020-023-006</span><span class="invisible">64-z</span></a> <a href="https://fosstodon.org/tags/PolycysticKidneyDisease" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>PolycysticKidneyDisease</span></a> <a href="https://fosstodon.org/tags/Pkd" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Pkd</span></a> <a href="https://fosstodon.org/tags/Adpkd" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Adpkd</span></a> <a href="https://fosstodon.org/tags/DrugRepurposing" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>DrugRepurposing</span></a> <a href="https://fosstodon.org/tags/SignatureReversion" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>SignatureReversion</span></a></p>